Description
Repro-Med Systems Inc designs, manufactures and markets proprietary portable and innovative medical devices, primarily for the ambulatory infusion market. Its Core domestic and international revenues consist of sales of products for the delivery of subcutaneous immunoglobulin to treat Primary Immunodeficiency Diseases, Chronic Inflammatory Demyelinating Polyneuropathy, and other disease states that are FDA cleared for use with the KORU Medical syringe driver. Novel therapies consist of sales of infusion systems for feasibility trials of biopharmaceutical companies in the drug development process as well as non-recurring engineering services revenues received from biopharmaceutical companies to ready or customize the FREEDOM System for clinical and commercial use.
